Schleiss, M. R., Bernstein, D. I., McVoy, M. A., Stroup, G., Bravo, F., Creasy, B., . . . Hallenberger, S. (2005). The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Schleiss, Mark R., David I. Bernstein, Michael A. McVoy, Greg Stroup, Fernando Bravo, Blaine Creasy, Alistair McGregor, Kristin Henninger, e Sabine Hallenberger. The Non-nucleoside Antiviral, BAY 38-4766, Protects against Cytomegalovirus (CMV) Disease and Mortality in Immunocompromised Guinea Pigs. 2005.

Schleiss, Mark R., et al. The Non-nucleoside Antiviral, BAY 38-4766, Protects against Cytomegalovirus (CMV) Disease and Mortality in Immunocompromised Guinea Pigs. 2005.